CLASS III Drug recall · Reported 10 Apr 2013 · FDA Enforcement Report

Tizanidine Tablets recalled by Dr. Reddy'S Laboratories

Dr. Reddy's Laboratories is recalling Tizanidine Tablets USP per, distributed nationwide in the US. The recall was initiated on 19 Mar 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.
NDC55111-179, 55111-180
UPC0355111180104, 0355111179108
Quantity recalled117,546 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-238-2013
FDA event ID
64733
Recalling firm
Dr. Reddy's Laboratories, Bridgewater, NJ
Manufacturer
Dr. Reddy's Laboratories Limited
Classification
Class III
Status
Terminated
Recall initiated
19 Mar 2013
FDA classified
1 Apr 2013
Reported
10 Apr 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

19 Mar 2013Recall initiated by company
1 Apr 2013Classified by FDA+13 days
10 Apr 2013Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Product as listed by the FDA

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

Where it was distributed

Nationwide and Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Which lots are affected?

Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Where was it sold?

Nationwide and Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Tizanidine recalls

All 12